Tau Imaging in Parkinson Disease (PD) Dementia

This study will use PET ('Positron Emission Tomography') neuroimaging to determine the amount of tau protein in the brain and to explore the relationship between presence of tau and clinical course of Parkinson's disease (PD) and dementia with Lewy bodies (DLB). Participants in the study will also receive other types of brain scans such as an MRI ('Magnetic Resonance Imaging') and take memory tests.

More information on the study is attached.


For more information, please contact Parisa Oviedo, Research Coordinator.